| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 2,4,6-trichlorophenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00962
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Fungicide |
| DME Modulation |
2,4,6-trichlorophenol inhibits the expression of DME HSD3B1 |
[1] |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Pentachlorophenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01605
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Pentachlorophenol inhibits the expression of DME HSD3B1 |
[2] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Fipronil |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Fipronil inhibits the expression of DME HSD3B1 |
[3] |
| Formaldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde up-regulates the expression of DME HSD3B1 |
[4] |
| Ochratoxin A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Ochratoxin A induces the drug-metabolizing activity of DME HSD3B1 |
[5] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME HSD3B1 |
[6] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME HSD3B1 |
[7] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
| Calcitriol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Calcitriol up-regulates the expression of DME HSD3B1 |
[8] |
| Diethylstilbestrol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00166
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Diethylstilbestrol inhibits the expression of DME HSD3B1 |
[9] |
| Estradiol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol up-regulates the expression of DME HSD3B1 |
[9] |
| Isotretinoin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00186
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Isotretinoin inhibits the expression of DME HSD3B1 |
[10] |
| Mitotane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00064
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Mitotane inhibits the drug-metabolizing activity of DME HSD3B1 |
[11] |
| Testosterone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Testosterone inhibits the expression of DME HSD3B1 |
[12] |
| Arbutin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00461
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Arbutin inhibits the expression of DME HSD3B1 |
[13] |
| Nadide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01390
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Nadide up-regulates the expression of DME HSD3B1 |
[14] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Diethyltoluamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Diethyltoluamide inhibits the expression of DME HSD3B1 |
[3] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME HSD3B1 |
[15] |
| Sulindac sulfide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00656
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Sulindac sulfide inhibits the drug-metabolizing activity of DME HSD3B1 |
[16] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Go-6976 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01321
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Go-6976 up-regulates the expression of DME HSD3B1 |
[17] |
| SB-431542 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01147
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
SB-431542 up-regulates the expression of DME HSD3B1 |
[18] |
|
|
|
|
|
|